CAS: 180468-42-2; (S)-Ethyl 1-Phenyl-3,4-Dihydroisoquinoline-2(1H)-Carboxylate

该化合物是一种多种用途的有机化合物,在制药研究中具有重要用途,其纯度和稳定性很高,便于在合成复杂分子时使用,其独特的结构特征与各种反应条件非常相容,使它成为新化合物开发中的理想构件.

结构式图片

相似化合物

180468-41-1 1035272-88-8 1353274-25-5

欧盟法规

C&L通报

上下游产品

索利那新杂质32 (S)-1,2,3,4-Tetrahydro-1-Phenyl-Isoquinoline-2-Carboxylic Acid 1035272-88-8
索非那新 Solifenacin 242478-37-1
4-Nitrophenyl-1-Phenyl-3,4-Dihydroisoquinoline-2(1H)-Carboxylate 881834-78-2
(S)-1-苯基-1,2,3,4-四氢异喹啉 (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline 118864-75-8
1-苯基-1,2,3,4-四氢异喹啉 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline 22990-19-8
(R)-1-苯基-1,2,3,4-四氢异喹啉 (R)-(-)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline 180272-45-1

合成工艺路线路线简述

    2-(2-溴乙基)苯甲醛置于盐酸,Sodium Hydride,Copper(II) Sulfate,三乙胺体系中,用 四氢呋喃,1,4-二氧六环,甲醇,乙醚,二氯甲烷,甲苯,Mineral Oil 用作溶剂,化学反应 25.17H,反应生成(S)-1-苯基-1,2,3,4-四氢-2-异喹啉甲酸乙酯
    参考文献:Stereoselective Total Syntheses Of Solifenacin And N-Acetyl-1-(4-Chlorophenyl)-6,7-Dimethoxytetrahydroisoquinoline
    标题:Stereoselective Total Syntheses Of Solifenacin And N-Acetyl-1-(4-Chlorophenyl)-6,7-Dimethoxytetrahydroisoquinoline
    摘要:A Highly Stereoselective Synthesis Of 1-Aryl-1,2,3,4-Tetrahydroisoquinoline Drugs Such As Solefinacin (Muscarinic Acetylcholine Receptor Antagonist) And N-Acetyl-1-(4-Chlorophenyl)-6,7-Dimethoxytetrahydroisoquinoline (Ampa Receptor Antagonist) Has Been Accomplished Using (R)-Tert-Butanesulfinamide As A Chiral Source. Chiral Tetrahydroisoquinolines Have Been Prepared Through The Aryl Grignard Addition To Chiral N-Sulfinylimines Followed By Haloamide Cyclization.
    Doi:10.1055/s-0034-1378515

    海关参考信息

    专利信息


    专利号:US-7741489-B2
    优先权日:2007-03-30
    标题:Process for the synthesis of solifenacin
    发明人:PUIG SERRANO JORDI; CAMPS PELAYO
    权利人:MEDICHEM SA
    摘要:The present invention provides an improved synthetic strategy for the preparation of solifenacin and pharmaceutically acceptable salts thereof.

    专利号:US-2011077405-A1
    优先权日:2008-05-23
    标题:Process for preparation of enantiomerically pure (s)-1-phenyi-1,2,3,4- tetrahydroisoquinoline
    发明人:ZEGROCKA-STENDEL OLIWIA; ZAGRODZKA JOANNA; LASZCZ MARTA
    权利人:ZEGROCKA-STENDEL OLIWIA; ZAGRODZKA JOANNA; LASZCZ MARTA
    摘要:Process for preparation of (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline wherein 1-phenyl-1,2,3,4-tetrahydroisoquinoline is reacted with D-(−)-tartaric acid in a solvent system comprising of methanol and water, preferably at 3.3:1 to 1:1 volume ratio, the crystallization mixture is left for crystallization and (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline is released from obtained crystalline diastereoisomeric salt according to standard procedures. (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline is the intermediate in enantiomeric synthesis of solifenacin.

    专利号:US-2009326230-A1
    优先权日:2006-07-19
    标题 :Process for preparing solifenacin and its salts
    发明人:MATHAD VIJAYAVITTHAL THIPPANNACHAR; LILAKAR JAYDEEPKUMAR DAHYABHAI; GILLA GOVERDHAN; KIKKURU SRIRAMIREDDY; CHINTA RAVEENDRA REDDY; DUDIPALA SWAROOPA
    权利人:REDDYS LAB LTD DR; REDDYS LAB INC DR
    摘要:The present invention relates to solifenacin in solid form and a process for its preparation and to a process for the preparation of (1S)-1-Phenyl-1,2,3,4-tetrahydro-isoquinoline, a key intermediate in the synthesis of solifenacin and its salts.

    专利号:US-2010029944-A1
    优先权日:2006-11-22
    标题:Process for the Synthesis of Solifenacin
    发明人:PUIG JORDI; SANCHEZ LAURA; MASLLORENS ESTER; AUGER IGNASI; BOSCH JORDI
    权利人:CORPORACION MEDICHEM S L
    摘要:This invention provides improved methods for making solifenacin and pharmaceutically acceptable salts thereof. The instant methods are unexpectedly advantageous in their simplicity and efficiency.

    专利号:WO-2008120080-A2
    优先权日:2007-03-30
    标 题:An improved process for the synthesis of solifenacin

    专利号:US-2008242697-A1
    优先权日:2007-03-30
    标题 :Process for the synthesis of solifenacin
    重庆卡兰医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.conier.com
    企业联系电话:023-62922305,18523575427👤
    📞重庆卡兰医药有限公司 ⚠️参考联系方式
    联系人:彭亮
    电话:023-62922305,18523575427
    手机:18523575427
    传真:023-62922305
    邮箱:2254263770@qq.com
    通信地址: 重庆市南岸区南坪亚太商谷5栋11楼
    邮编: 400060
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:重庆市南岸区南坪亚太商谷5栋11楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    重庆英斯凯化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ensky-chemical.com
    电话: 86-023-86815286 86815288👤
    📞重庆英斯凯化工有限公司 ⚠️参考联系方式

    销售电话:86-023-86815286 86815288
    邮箱:sales@ensky-chemical.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    重庆市长寿区凤城李家坪(川染厂内)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Enantioselective Iridium-Catalyzed Hydrogenation Of 1- And 3-Substituted Isoquinolinium Salts
    作者:Zhi-Shi Ye,Ran-Ning Guo,Xian-Feng Cai,Mu-Wang Chen,Lei Shi,Yong-Gui Zhou |发布日期:2013.3.25
    摘要:Asymmetric Hydrogenation: The Title Reaction Provides An Efficient And Rapid Access To Chiral 1‐ And 3‐substituted 1,2,3,4‐tetrahydroisoquinolines With Excellent Enantioselectivity (See Scheme; L=ligand). A Preliminary Mechanistic Study Indicates That The 1,2‐hydride Addition Might Be The Initial Step In The Reaction. The Method Has Been Used In The Synthesis Of Urinary Antispasmodic Drug (+)‐solifenacin

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2006).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知